Shopping Cart 0
Cart Subtotal
USD 0

AbbVie Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 525
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

AbbVie Inc.-Strategy, SWOT and Corporate Finance Report

Summary

AbbVie Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

AbbVie Inc. (AbbVie or 'the company') is a research-based biopharmaceutical company. It classifies its business into one segment: Pharmaceutical Products. Its pharmaceuticals product portfolio consists mainly of Humira (adalimumab) and products in therapeutic areas of oncology, metabolics/hormone, endocrinology, and virology. The company operates in the US, Canada, Mexico, European Union, Japan, Brazil and other countries. It is headquartered in North Chicago, Illinois.

Scope

- Detailed information on AbbVie Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis

- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments

- Intelligence on AbbVie Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about AbbVie Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AbbVie Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess AbbVie Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on AbbVie Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

AbbVie Inc.: Company Overview 9

AbbVie Inc.: Overview and Key Facts 9

AbbVie Inc.: Overview 9

AbbVie Inc.: Key Facts 9

AbbVie Inc.: Key Employees 11

AbbVie Inc.: Key Employee Biographies 12

AbbVie Inc.: Major Products and Services 18

AbbVie Inc.: Company History 19

AbbVie Inc.: Management Statement 27

AbbVie Inc.: Locations and Subsidiaries 29

AbbVie Inc.: Key Competitors 31

AbbVie Inc.: Company Analysis 32

AbbVie Inc.: Business Description 32

AbbVie Inc.: SWOT Analysis 34

AbbVie Inc.: SWOT Overview 34

AbbVie Inc.: Strengths 34

AbbVie Inc.: Weaknesses 35

AbbVie Inc.: Opportunities 36

AbbVie Inc.: Threats 38

AbbVie Inc.: Corporate Financial Deals Activity 40

AbbVie Inc.: Financial Deals Overview 40

AbbVie Inc.: Targets and Partners 42

AbbVie Inc.: Top Deals 2014-2018YTD 45

AbbVie Inc.: Advisors 46

AbbVie Inc.: Top Legal Advisors 46

AbbVie Inc.: Top Financial Advisors 46

AbbVie Inc.: Mergers and Acquisitions 47

AbbVie Inc.: Corporate Venturing 48

AbbVie Inc.: Capital Raising 49

AbbVie Inc.: Partnership 50

AbbVie Inc.: Recent Developments 51

AbbVie Inc.: News and Events Summary 51

AbbVie Inc.: Contracts 55

AbbVie Inc.: Corporate Governance 56

AbbVie Inc.: Corporate Social Responsibility 57

AbbVie Inc.: Financial Deals 58

AbbVie Inc.: Financial Performance 58

AbbVie Inc.: Market Developments 58

AbbVie Inc.: Regulatory and Legal Events 59

AbbVie Inc.: Strategy and Operations 60

Appendix 61

Contact Us 61

Methodology 61

About MarketLine 62


List Of Figure

List of Figures

Figure 1: AbbVie Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: AbbVie Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: AbbVie Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: AbbVie Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Figure 5: AbbVie Inc.: M&A Activity by Geography (2014-YTD 2018)

Figure 6: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Figure 7:

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

AbbVie Inc.-Strategy, SWOT and Corporate Finance Report

Summary

AbbVie Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

AbbVie Inc. (AbbVie or 'the company') is a research-based biopharmaceutical company. It classifies its business into one segment: Pharmaceutical Products. Its pharmaceuticals product portfolio consists mainly of Humira (adalimumab) and products in therapeutic areas of oncology, metabolics/hormone, endocrinology, and virology. The company operates in the US, Canada, Mexico, European Union, Japan, Brazil and other countries. It is headquartered in North Chicago, Illinois.

Scope

- Detailed information on AbbVie Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis

- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments

- Intelligence on AbbVie Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about AbbVie Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AbbVie Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess AbbVie Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on AbbVie Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

AbbVie Inc.: Company Overview 9

AbbVie Inc.: Overview and Key Facts 9

AbbVie Inc.: Overview 9

AbbVie Inc.: Key Facts 9

AbbVie Inc.: Key Employees 11

AbbVie Inc.: Key Employee Biographies 12

AbbVie Inc.: Major Products and Services 18

AbbVie Inc.: Company History 19

AbbVie Inc.: Management Statement 27

AbbVie Inc.: Locations and Subsidiaries 29

AbbVie Inc.: Key Competitors 31

AbbVie Inc.: Company Analysis 32

AbbVie Inc.: Business Description 32

AbbVie Inc.: SWOT Analysis 34

AbbVie Inc.: SWOT Overview 34

AbbVie Inc.: Strengths 34

AbbVie Inc.: Weaknesses 35

AbbVie Inc.: Opportunities 36

AbbVie Inc.: Threats 38

AbbVie Inc.: Corporate Financial Deals Activity 40

AbbVie Inc.: Financial Deals Overview 40

AbbVie Inc.: Targets and Partners 42

AbbVie Inc.: Top Deals 2014-2018YTD 45

AbbVie Inc.: Advisors 46

AbbVie Inc.: Top Legal Advisors 46

AbbVie Inc.: Top Financial Advisors 46

AbbVie Inc.: Mergers and Acquisitions 47

AbbVie Inc.: Corporate Venturing 48

AbbVie Inc.: Capital Raising 49

AbbVie Inc.: Partnership 50

AbbVie Inc.: Recent Developments 51

AbbVie Inc.: News and Events Summary 51

AbbVie Inc.: Contracts 55

AbbVie Inc.: Corporate Governance 56

AbbVie Inc.: Corporate Social Responsibility 57

AbbVie Inc.: Financial Deals 58

AbbVie Inc.: Financial Performance 58

AbbVie Inc.: Market Developments 58

AbbVie Inc.: Regulatory and Legal Events 59

AbbVie Inc.: Strategy and Operations 60

Appendix 61

Contact Us 61

Methodology 61

About MarketLine 62


List Of Figure

List of Figures

Figure 1: AbbVie Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: AbbVie Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: AbbVie Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: AbbVie Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Figure 5: AbbVie Inc.: M&A Activity by Geography (2014-YTD 2018)

Figure 6: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Figure 7:

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com